Clinical trial
Caesarean and Corticotherapy
NCT00446953 · University Hospital, Strasbourg, France, Other · Completed
Key facts
| NCT number | NCT00446953 |
|---|---|
| Title | Caesarean and Corticotherapy |
| Official title | Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date. |
| Lead sponsor | University Hospital, Strasbourg, France, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neonatal Distress |
| Intervention type | Drug, Other |
| Interventions | betamethasone, placebo |
| Enrollment | 200 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | Mar 13, 2007 |
| Last update posted | Dec 22, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: